About 180,000 results
Open links in new tab
  1. Tardive Dyskinesia Treatment | AUSTEDO XR® (deutetrabenazine)

    Reduce involuntary movements with AUSTEDO XR® (deutetrabenazine) tablets treatment for TD. See safety info and boxed warning.

  2. Tardive Dyskinesia (TD) | AUSTEDO XR® (deutetrabenazine) …

    AUSTEDO XR ® (deutetrabenazine) extended-release tablets and AUSTEDO ® (deutetrabenazine) tablets are indicated in adults for the treatment of chorea associated with …

  3. Austedo (deutetrabenazine): Uses, Side Effects, Dosage Guide

    Aug 20, 2025 · Austedo's drug class is a VMAT2 inhibitor (vesicular monoamine transporter 2 inhibitor). Austedo tablets are taken twice daily, and the Austedo XR (extended-release) …

  4. Patients Taking AUSTEDO XR® (deutetrabenazine)

    Sep 21, 2025 · AUSTEDO XR and AUSTEDO® are the first vesicular monoamine transporter 2 (VMAT2) inhibitors approved by the U.S. Food and Drug Administration in adults for the …

  5. The safety and effectiveness of AUSTEDO XR and AUSTEDO have not been established in pediatric patients for the treatment of chorea associated with Huntington’s disease or for the …

  6. FDA Approves One Pill, Once-Daily Tablets of Deutetrabenazine …

    May 30, 2024 · The FDA has approved a new one-pill, once-daily tablet administration option for deutetrabenazine (Austedo XR; Teva Pharmaceuticals), a medication for tardive dyskinesia …

  7. Austedo XR Approved: A New Treatment Option for Tardive Dyskinesia

    May 30, 2024 · The US Food and Drug Administration (FDA) has approved Teva Pharmaceuticals’ Austedo XR (deutetrabenazine) as a once-daily pill treatment option, …

  8. Austedo: Package Insert / Prescribing Information / MOA - Drugs.com

    Mar 9, 2025 · The efficacy of AUSTEDO in the treatment for tardive dyskinesia was established in two 12‑week, randomized, double-blind, placebo-controlled, multi-center trials conducted in …

  9. Teva Pharmaceutical Industries Ltd. - Teva Announces AUSTEDO® XR

    May 29, 2024 · AUSTEDO XR (deutetrabenazine) extended-release tablets and AUSTEDO ® (deutetrabenazine) tablets are indicated in adults for the treatment of chorea associated with …

  10. AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR ...

    Nov 7, 2025 · The findings demonstrate that treatment with AUSTEDO (deutetrabenazine) tablets or AUSTEDO XR (deutetrabenazine) extended-release tablets for tardive dyskinesia (TD) led …